Original air date:
Saturday, October 26, 2019
Running time: 14:26 minutes
Shamir R. Mehta, MD, MSc, FRCPC, FACC, FESC
Robert Welsh, MD, FRCPC, FACC, FAHA, FESC
Watch Dr. Shamir R. Mehta and Dr. Robert Welsh discuss the highlights of the symposium entitled The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients? presented at the Canadian Cardiovascular Congress in October 2019.
Therapeutic area: Cardiology/Vascular Disease